Edition:
United Kingdom

Citius Pharmaceuticals Inc (CTXR.OQ)

CTXR.OQ on NASDAQ Stock Exchange Capital Market

1.28USD
22 Mar 2019
Change (% chg)

$-0.14 (-9.86%)
Prev Close
$1.42
Open
$1.42
Day's High
$1.44
Day's Low
$1.28
Volume
8,922
Avg. Vol
23,070
52-wk High
$3.25
52-wk Low
$0.86

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Dec 0.00 -0.218
FY 2018 Sep '18 0.00 -0.209
Jun '18 0.00 -0.189
Mar '18 0.00 -0.442
Dec 0.00 -0.377
FY 2017 Sep '17 0.00 -0.448
Jun '17 0.00 -0.489
Mar '17 0.00 -0.549
Dec 0.00 -0.444
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Quarter Ending Jun-19 1 0.00 0.00 0.00 --
Year Ending Sep-19 1 0.00 0.00 0.00 --
Year Ending Sep-20 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-19 1 -0.20 -0.20 -0.20 --
Quarter Ending Jun-19 1 -0.06 -0.06 -0.06 --
Year Ending Sep-19 1 -0.56 -0.56 -0.56 --
Year Ending Sep-20 1 0.06 0.06 0.06 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.30 32.54
P/E High - Last 5 Yrs. -- 43.23 48.15
P/E Low - Last 5 Yrs. -- 22.71 23.42
Beta -- 0.86 0.87
Price to Sales (TTM) -- 6.59 8.39
Price to Book (MRQ) 1.38 5.12 5.27
Price to Tangible Book (MRQ) -- 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 3.99 4.70
Payout Ratio(TTM) -- 42.18 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 8.02
Sales - 5 Yr. Growth Rate -- 10.48 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago 34.47 45.67 47.68
EPS (TTM) vs TTM 1 Yr. Ago 0.90 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.47
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) 0.06 2.87 2.98
LT Debt to Equity (MRQ) 0.00 8.87 11.35
Total Debt to Equity (MRQ) 46.72 12.87 16.02
Interest Coverage (TTM) -3.13 32.47 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 52.10 52.41
Gross Margin - 5 Yr. Avg. -- 49.66 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.26 12.43
Operating Margin (TTM) -- 13.53 5.77
Operating Margin - 5 Yr. Avg. -- 13.69 8.02
Pre-Tax Margin (TTM) -- 11.90 4.80
Pre-Tax Margin - 5 Yr. Avg. -- 14.11 8.31
Net Profit Margin (TTM) -- 8.81 1.53
Net Profit Margin - 5 Yr. Avg. -- 10.60 4.72
Effective Tax Rate (TTM) -- 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 928,329,132 820,307,541
Net Income/Employee (TTM) -- 105,132,015 92,854,576
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -44.55 10.98 10.60
Return on Assets - 5 Yr. Avg. -- 12.41 11.78
Return on Investment (TTM) -66.76 14.23 13.82
Return on Investment - 5 Yr. Avg. -- 16.18 15.32
Return on Equity (TTM) -66.76 15.46 15.25
Return on Equity - 5 Yr. Avg. -- 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -67.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Citius Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.00 -6.35 24 31
13 Week -48.41 -50.92 4 42
26 Week -65.60 -68.22 3 45
52 Week -72.71 -76.87 4 9
YTD -52.67 -58.43 6 37
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.01%
# of Holders: 10
Total Shares Held: 927,991
3 Mo. Net Change: 671,607
# New Positions: 1
# Closed Positions: 5
# Increased Positions: 5
# Reduced Positions: 6
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.